All In Biotech

Free tool

FAERS Monitor: Macrobid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020064 or its brand name (Macrobid, Nitrofurantoin, Nitrofurantoin, Macrocrystalline). Reports on generic versions are filed under their own applications.

Reports

5,883

Serious

4,020

68% of reports

Hospitalization

1,958

Death reported

335

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • urinary tract infection820
  • headache623
  • nausea590
  • drug hypersensitivity552
  • fatigue537
  • pain505
  • dyspnoea444
  • drug ineffective438
  • off label use398
  • diarrhoea373
  • dizziness370
  • vomiting347
  • asthenia318
  • pyrexia304
  • fall300

Reports by year received

View as table
YearReports
200485
200583
2006103
200780
200899
2009126
2010177
2011249
2012274
2013227
2014329
2015385
2016500
2017406
2018400
2019432
2020469
2021294
2022255
2023249
2024229
2025261
2026171

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,276 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
urinary tract infectionSignal82017.316.212,590
drug hypersensitivitySignal55210.29.44,614
headacheSignal6233.63.31,175
fallSignal3003.22.9465
pyrexiaSignal3043.12.8449
astheniaSignal3183.02.7437
painSignal5052.92.7664
dyspnoeaSignal4442.82.6528
nauseaSignal5902.72.5636
dizzinessSignal3702.72.4388
vomitingSignal3472.62.4360
fatigueSignal5372.52.3485
diarrhoeaSignal3732.11.9211
off label use3981.61.599
drug ineffective4381.21.114

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.